Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term with monetary and in kind donations
FDA grants Fast Track designation for the treatment of chronic kidney disease, underscoring urgent need for new treatments for people living with the condition
At Boehringer Ingelheim we are giving patients new hope. We are collaborating with the oncology community on a shared journey to deliver leading science.